TY - JOUR AU - Schroeder, Carl AU - Meng, Jianghong AU - Zhao, Shaohua AU - DebRoy, Chitrita AU - Torcolini, Jocelyn AU - Zhao, Cuiwei AU - McDermott, Patrick AU - Wagner, David AU - Walker, Robert AU - White, David T1 - Antimicrobial Resistance of Escherichia coli O26, O103, O111, O128, and O145 from Animals and Humans T2 - Emerging Infectious Disease journal PY - 2002 VL - 8 IS - 12 SP - 1409 SN - 1080-6059 AB - Susceptibilities to fourteen antimicrobial agents important in clinical medicine and agriculture were determined for 752 Escherichia coli isolates of serotypes O26, O103, O111, O128, and O145. Strains of these serotypes may cause urinary tract and enteric infections in humans and have been implicated in infections with Shiga toxin–producing E. coli (STEC). Approximately 50% of the 137 isolates from humans were resistant to ampicillin, sulfamethoxazole, cephalothin, tetracycline, or streptomycin, and approximately 25% were resistant to chloramphenicol, trimethoprim-sulfamethoxazole, or amoxicillin-clavulanic acid. Approximately 50% of the 534 isolates from food animals were resistant to sulfamethoxazole, tetracycline, or streptomycin. Of 195 isolates with STEC-related virulence genes, approximately 40% were resistant to sulfamethoxazole, tetracycline, or streptomycin. Findings from this study suggest antimicrobial resistance is widespread among E. coli O26, O103, O111, O128, and O145 inhabiting humans and food animals. KW - Escherichia coli KW - E. coli KW - antimicrobial resistance KW - Shiga toxin KW - STEC KW - United States KW - Argentina KW - Saudi Arabia KW - Canada KW - Mexico KW - Zambia KW - Singapore DO - 10.3201/eid0812.020070 UR - https://wwwnc.cdc.gov/eid/article/8/12/02-0070_article ER - End of Reference